Last, RBM39, a ribonucleoprotein involved in splicing through interaction with U2AF2 and SF3B1, as well as a regulator of SRSF10 and hnRNPH1, has been shown to be overexpressed in AML cells as compared to normal CD34+ cells. The gene discussed is CD34; the disease is acute myeloid leukemia.